Nexome Capital Markets is a financial services firm that provides merchant banking, corporate advisory, and debt syndication services while managing a proprietary investment portfolio of stocks and mutual funds.
The company lacks a durable competitive advantage, as evidenced by an average ROCE of 1.8% and a declining revenue CAGR of -10.9%, indicating no pricing power or cost advantage in a fragmented advisory market.
Capital has been primarily directed toward proprietary investments in securities and mutual funds rather than high-return business expansion, resulting in low single-digit returns on equity and capital employed.
The business failed because it functioned as a mediocre closed-end fund masquerading as a financial services firm. Management continued to funnel capital into low-yield proprietary investments rather than productive business expansion, while the core advisory revenue continued its double-digit contraction. The lack of scale and pricing power eventually led to fixed costs consuming the thin 3.4% net margins, and the 'remote recovery' of court-deposited funds proved to be a total loss, leaving shareholders with a stagnant pile of cash-equivalents that the market valued at a steep discount to book.
RichFakir rates Nexome Capital Markets Ltd's business quality as poor — 21/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Nexome Capital Markets Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Nexome Capital Markets Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Nexome Capital Markets Ltd's fair value is about ₹28 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →